MACD Bullish Stocks · Laboratory Analytical Instruments
9 stocks match the MACD Bullish Stocks screen. Stocks whose MACD line is above its signal line — a bullish momentum state, largest first. Filtered to Laboratory Analytical Instruments. Data as of close · Checked
| WAT | Waters Corporation | 0.80 | 14.73 | +0.40% | +4.27% | +21.52% | Golden | 51.88 | 38.3% | Bullish | Strongly Bullish | -6.81% | +58.83% | +1.59% | Double Bottom | — | 449.43 | -2.86% |
| BIO | Bio-Rad Laboratories, Inc. | 0.72 | 11.18 | -0.16% | -2.22% | +16.77% | Golden | 47.37 | 43.1% | Bullish | Bullish | -7.57% | +53.67% | +0.14% | Double Top | — | 366.22 | -1.57% |
| BRKR | Bruker Corp | 1.04 | 3.14 | -3.82% | -5.46% | +10.66% | Golden | 42.61 | 15.4% | Bullish | Bullish | -16.89% | +71.98% | -0.57% | Inverse Head and Shoulders | — | 55.66 | -2.48% |
| ALMR | Alamar Biosciences, Inc. | 1.07 | 2.70 | +0.89% | -5.30% | — | — | 47.24 | 47.8% | Bullish | Bullish | — | — | +3.17% | — | — | 28.91 | -5.48% |
| CTKB | Cytek Biosciences, Inc. | 0.97 | 0.28 | +3.65% | +9.13% | +24.17% | Golden | 54.47 | 51.8% | Bullish | Strongly Bullish | -8.69% | +74.36% | -0.33% | — | — | 5.78 | -5.56% |
| PACB | Pacific Biosciences Of California, Inc. | 2.02 | 0.28 | +3.16% | +26.63% | +45.46% | Golden | 53.77 | 46.9% | Bullish | Strongly Bullish | -31.78% | +117.67% | +2.68% | — | Bearish Marubozu | 2.34 | -10.34% |
| HBIO | HARVARD BIOSCIENCE INC | 6.81 | 0.33 | +4.79% | +7.27% | +60.53% | Golden | 56.85 | 78.0% | Bullish | Strongly Bullish | -3.49% | +2077.50% | +1.18% | Double Bottom | Bearish Engulfing | 8.71 | -2.35% |
| RPID | RAPID MICRO BIOSYSTEMS, INC. | 1.50 | 0.05 | -14.15% | -34.84% | -68.54% | Death | 24.92 | 0.0% | Bullish | Bearish | -85.67% | +0.00% | +1.63% | — | Bearish Marubozu | 0.70 | -5.07% |
| ASTC | ASTROTECH Corp | 2.39 | 0.31 | -12.65% | -24.95% | -33.58% | Death | 32.57 | 10.2% | Bullish | Bearish | -92.90% | +121.36% | -0.92% | Double Top | — | 4.87 | -0.31% |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.